People | June 22, 2026
Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla
Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.
Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.
Through the transaction, Aurobindo USA will expand its product portfolio in this segment while gaining a U.S.-based manufacturing facility
Acquisition of Mumbai-based pharmaceutical, nutraceutical and cosmeceutical company expected to be completed by July 2026
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation
Veteran healthcare executive to drive international growth, strategic partnerships, and global commercialization of the company's molecular diagnostics portfolio
Subscribe To Our Newsletter & Stay Updated
